BD Vialon

BD Vialon TM
Biomaterial
The Material Difference in Vascular Access

BD Vialon
B I O M A T E R I A L
C l i n i c a l l y S u p e r i o r
The Difference is
BD Vialon Biomaterial
BD Vialon Biomaterial is a
unique, proprietary biomaterial,
developed over a decade ago,
especially for vascular access.
BD Vialon biomaterial has been
proven to enhance clinical and
economic outcomes.
Multiple clinical investigations
conducted over ten years have
demonstrated that IV catheters
made of BD Vialon biomaterial
proved easier to insert, while
providing longer indwelling times
with improved patient outcomes.
A Smooth and Easy Insertion
The insertion
characteristics
of BD Vialon
biomaterial
catheters are
as unique as
the material itself. Superior tip
integrity, an ultra-smooth microsurface
and an exclusive lubrication
process enable the easiest
insertion possible, making
BD Vialon biomaterial catheters
easier to place and advance on a
wider cross-section of patients. 1
BD Insyte I.V. Catheter
Before Insertion
(75X enlargement)
BD Insyte I.V. Catheter
After Insertion
(75X enlargement)
Softens Inside the Vessel
Another distinctive characteristic
of BD Vialon biomaterial is its
ability to soften up to 70% while
in the vessel. 5
By conforming to the shape of
the vein, catheters made of
BD Vialon biomaterial reduce
the chance of irritation to the
vessel wall, which in turn
reduces the incidence of
mechanical phlebitis, a major
complication of IV therapy.
BD Vialon Biomaterial
FEP Polymer

Catheters made of BD Vialon biomaterial are
clinically proven to optimize patient outcomes.
Ease of
Insertion
Optimum Ease of Insertion
The sharp needle and patented
catheter tip taper enable a smooth
penetration through the skin and
into the vessel.
Results: “Ease of penetration
through the skin was signifi cantly
better with the Vialon cannulae.” 1
“Cannula tip damage was more
common with the Tefl on cannulae
(37.3%) than with the Vialon cannulae
(16.6%). This tip damage
was signifi cantly associated with
higher mean phlebitis scores.” 1
Optimum Kink Resistance
The BD Vialon biomaterial is signifi
cantly more fl exible than other
IV catheter materials. 5
Results: “Kinking was not found
in any of the Vialon cannulae after
removal. However, 29.3% of the
Tefl on cannulae had visible kinks
of the cannula shaft, usually at its
junction with the hub.” 2
Reduced Risk
Kink
+ Resistance + of Mechani-
Risk of IV + =
cal Phlebitis
Optimum Reduced Risk of
Mechanical Phlebitis
“Our data suggest a cost-effective
strategy for the use of intravenous
catheters to minimize the risk
for phlebitis ... for most patients
requiring prolonged peripheral
venous access, PEU-Vialon catheters
replaced every 3 or 4 days
would produce a lower incidence
of phlebitis than would FEP-
Tefl on catheters replaced every 2
days.” 2
Results: “... catheters made of
PEU-Vialon were substantially
less phlebitogenic than were catheters
made of FEP-Tefl on: The
reduction in risk was nearly 30%
overall; in severe phlebitis, the
reduction was nearly 50%.” 2
“… the nature of the cannulae was
the single most important factor
in the incidence and severity of
infusion thrombophlebitis, Vialon
cannulae being associated with
a 46% lower incidence than the
Tefl on type.” 1
“… the incidence of phlebitis in
the group receiving Vialon I.V.
catheters was 36 percent lower
than that of the group receiving
Tefl on I.V. catheters.” 4
Reduced
Infi ltration
Optimum
Indwelling
Time
Optimum Reduced Risk
of IV Infi ltration
Due to the superior softening
capabilities of the BD Vialon
biomaterial, it conforms to the
natural lie of the vessel, resulting
in less pressure to the vessel walls,
thereby reducing the risk of vessel
wall penetration by the catheter
material.
Results: “These multivariate
models showed that Vialon
catheter material reduced the risk
of infi ltration by 18%... in the
total sample and by 35%... in the
higher risk low-weight (≤ 1500 g)
subsample.” 3
1 P.B. Gaukroger, J.G. Roberts, and T.A. Manners.
“Infusion Thrombophlebitis: A Prospective Comparison
of 645 Vialon® and Tefl on® Cannulae in
Anaesthetic and Postoperative Use” Anaesthesia
and Intensive Care, August 1988, Volume 16,
No.3.
2 Dennis Maki, MD and Marilyn Ringer, BSN, MS.
“Risk Factors for Infusion-related Phlebitis with
Small Peripheral Venous Catheters” Annals of
Internal Medicine, 1991; 114:845-854.
3 Michael Stanley, MD, Emily Meister, RNC and
Kathryn Fuschuber, RN. “Infi ltration During
Intravenous Therapy in Neonates: Comparison of
Tefl on® and Vialon® Catheters” Southern Medical
Journal, September 1992, Volume 85, Number
9, Pages 883-886.
4 Joy M. McKee, RN, OCN, Judith A. Shell, RN,
MSN, OCN, Teresa A. Warren, RN, CIC, and V.
Paula Campbell, RN, OCN. “Complications of
Intravenous Therapy: A Randomized Prospective
Study – Vialon vs. Tefl on” Journal of Intravenous
Nursing, Vol. 12, No. 5, Sept./Oct. 1989.
5 Data on fi le.

With BD Vialon Biomaterial,
You’re Sure to Save
The BD SureSave TM
Analysis offered
by BD Medical will show
how catheters made of
BD Vialon biomaterial can reduce
the total cost of IV therapy by
enhancing fi rst-start effi ciency,
reducing restarts and increasing
indwelling times.
BD Vialon
B I O M A T E R I A L
C l i n i c a l l y S u p e r i o r
Ask for Catheters
Made of BD Vialon Biomaterial
BD Vialon biomaterial catheters
are available exclusively from BD.
The following product lines are
available in a variety of lengths
and gauges:
BD Insyte TM
Shielded IV Catheters
Autoguard TM
BD Saf-T-Intima TM
Closed IV Catheter System
BD Medical
9450 South State Street
Sandy, Utah 84070
1-888-237-2762
www.bd.com/infusion
BD, BD Logo and all other trademarks are
property of Becton, Dickinson and Company.
©2006 BD.
D12907-2 B(2-06)